Ensuring Community Access to Pharmacist Services Act
- Sponsor
- Rep. Smith, Adrian [R-NE-3]
- Committees
- Ways and Means Committee (primary)
- Last action
- May 21, 2026
Bottom line
The bill expands Medicare Part B coverage to include specific pharmacist-provided services, aiming to improve access to care for common conditions and during public health crises.
What it actually does
This bill amends the Social Security Act to include certain pharmacist services under Medicare Part B coverage, specifically for evaluation and management related to common respiratory illnesses (COVID-19, influenza, RSV, strep throat) and services addressing public health emergencies. It establishes a payment mechanism for these services and prohibits balance billing by pharmacists for Medicare beneficiaries. The changes are set to apply from January 1, 2026.
Proponents argue
Supporters argue that this bill will significantly improve patient access to essential healthcare services, particularly in rural and underserved areas where pharmacists are often the most accessible healthcare providers. By allowing pharmacists to be reimbursed for services within their state-authorized scope of practice, the bill leverages an underutilized healthcare workforce, reduces the burden on physicians, and enhances the healthcare system's capacity to respond to public health emergencies.
Opponents contend
Critics may contend that expanding Medicare coverage for pharmacist services without clear federal guidelines on scope of practice could lead to inconsistent care quality across states due to varying state laws. Concerns might also be raised about the potential increased costs to the Medicare program and whether pharmacists have adequate training and infrastructure to manage these expanded services effectively without direct physician oversight in all circumstances.
The bill is concise and straightforward, allowing for a quick and informed evaluation by a reader.
Section 2(a), amending Section 1861(s)(2) and adding (nnn) of the Social Security Act
Medicare Part B Coverage for Pharmacist Services
This provision adds 'pharmacist services' to the list of services covered under Medicare Part B. It defines these services as those a pharmacist is legally authorized to perform under state law, including related supplies, that would otherwise be covered if provided by a physician. Specifically, it covers visits for evaluation and management of COVID-19, influenza, RSV, or streptococcal pharyngitis, and other testing or treatment services addressing a declared public health emergency. These services must be furnished under physician supervision or collaboration if required by state law.
Supporters argue
Supporters argue this provision is crucial for modernizing healthcare delivery, recognizing pharmacists' clinical capabilities, and improving public health preparedness by expanding the pool of providers who can offer essential services, particularly during outbreaks or emergencies.
Critics contend
Opponents may argue that without uniform federal standards for pharmacist training and scope of practice, relying on varied state laws could lead to inconsistencies in care quality and patient safety. They might also express concerns about potential fragmentation of care if pharmacists operate too independently from primary care physicians.
Tradeoffs
The provision balances the desire to expand access to care and leverage the pharmacist workforce against concerns about maintaining consistent quality of care and ensuring appropriate integration with existing medical practices, especially given the reliance on diverse state-level regulations.
Section 2(b), amending Section 1833(a)(1) of the Social Security Act
Medicare Part B Payment for Pharmacist Services
This section specifies how pharmacist services will be paid under Medicare Part B. Generally, Medicare will pay 80% of the lesser of the actual charge or 85% of the amount determined under the physician fee schedule (Section 1848). However, for services addressing a public health need during a declared public health emergency, the payment will be 100% of the amount determined under the physician fee schedule.
Section 2(c), amending Section 1842(b)(18) of the Social Security Act
Prohibition on Balance Billing for Pharmacist Services
This section extends the existing prohibition on balance billing to pharmacists providing covered Medicare Part B services. This means pharmacists cannot charge Medicare beneficiaries more than the Medicare-approved amount for the services they provide under this new coverage. This protects beneficiaries from unexpected out-of-pocket costs beyond their standard coinsurance or deductible.
The definition of 'pharmacist services' explicitly states that such services must be furnished 'under the supervision of, or working in collaboration with, a physician or practitioner... in the manner and to the extent as so required by such State law.' It also defines 'collaboration' as a process within the pharmacist's scope, with medical direction and appropriate supervision 'as defined by the law of the State in which the services are performed.'
Section 2(a)(2), adding Section 1861(nnn)(1)(A) and (2) of the Social Security Act
Why it matters:This is standard legislative practice to defer to state professional licensing and practice laws, avoiding federal preemption where possible. However, it means the practical impact of the bill will vary significantly by state.
Case for: Supporters argue that deferring to state law respects the existing regulatory frameworks for healthcare professionals and allows for flexibility based on local needs and professional standards. It avoids a one-size-fits-all federal mandate that might not align with diverse state practices.
Case against: Critics might argue that this reliance on varied state laws could lead to an uneven rollout of services, with some states being much slower or more restrictive in enabling pharmacists to provide these services. This could create disparities in access for Medicare beneficiaries depending on their state of residence.
Estimated impact: The practical scope and availability of covered pharmacist services will be directly determined by the specific laws and regulations in each state, potentially leading to significant regional variation in access and utilization.
The bill specifies a 100% payment rate (of the physician fee schedule amount) for pharmacist services that 'address a public health need related to a public health emergency declared under section 319 of the Public Health Service Act (as determined by the Secretary).' This is a higher rate than the 85% for routine services.
Section 2(b), amending Section 1833(a)(1) of the Social Security Act
Why it matters:This is a targeted incentive designed to ensure robust participation from pharmacists during public health crises, reflecting a policy priority. It's not intentionally hidden but is a specific detail within a broader payment structure.
Case for: Proponents argue that the 100% payment rate during public health emergencies is a critical incentive to mobilize pharmacists rapidly and broadly, ensuring maximum access to testing and treatment when the nation faces a health crisis. It removes financial barriers for both providers and patients during critical times.
Case against: Some might argue that a 100% payment rate could be seen as overly generous or could create an incentive for over-utilization during declared emergencies, potentially leading to higher federal expenditures without sufficient oversight.
Estimated impact: This provision could significantly increase federal spending during future public health emergencies by fully covering pharmacist services, but it aims to enhance the nation's response capacity.